J. T. Kodra

发表

Redesigning nucleic acids

Martin Egli, Stefan Lutz, Daniel Hutter, 1998, Pure and applied chemistry. Chimie pure et appliquee.

Small-molecule agonists for the glucagon-like peptide 1 receptor

Jeppe Sturis, Jarek Kostrowicki, Carsten Behrens, 2007, Proceedings of the National Academy of Sciences.

Structural insight into antibody-mediated antagonism of the Glucagon-like peptide-1 Receptor

S. G. Rønn, P. S. Gandhi, Xiaoai Wu, 2016, Scientific Reports.

Rescue of a pathogenic mutant human glucagon receptor by pharmacological chaperones.

Xiaohong Liu, Chun-Rong Chen, J. T. Kodra, 2012, Journal of molecular endocrinology.

Molecular Engineering of Efficacious Mono-Valent Ultra-Long Acting Two-Chain Insulin-Fc Conjugates.

L. De Maria, Zhaosheng Lin, T. Pedersen, 2022, Journal of medicinal chemistry.

Stability of oligodeoxynucleoside phosphorodithioates and phosphorothioates in aqueous ammonia.

J. Kehler, J. T. Kodra, O. Dahl, 1995, Nucleic acids research.

Oligomer extended insulin-fc conjugates

Zhaosheng Lin, M. Münzel, J. T. Kodra, 2018 .

Small molecule ago-allosteric modulators of the human glucagon-like peptide-1 (hGLP-1) receptor.

J. Holst, J. D. de Jong, Michael D. Johnson, 2007, Bioorganic & medicinal chemistry letters.

Chemistry and enzymology of an expanded genetic alphabet

J. T. Kodra, 1998 .

Long acting analogue of the calcitonin gene-related peptide induces positive metabolic effects and secretion of the glucagon-like peptide-1.

B. Hartmann, K. Raun, C. Nilsson, 2016, European journal of pharmacology.

Human glucagon receptor antagonists with thiazole cores. A novel series with superior pharmacokinetic properties.

C. Behrens, L. B. Knudsen, E. Nishimura, 2009, Journal of medicinal chemistry.

Novel glucagon receptor antagonists with improved selectivity over the glucose-dependent insulinotropic polypeptide receptor.

C. Behrens, L. B. Knudsen, E. Nishimura, 2008, Journal of medicinal chemistry.

Phenylselenium Trichloride, Preparation and Use as a Vinylic Chlorination Reagent

N. Stuhr-Hansen, J. T. Kodra, L. Henriksen, 1996 .

Synthesis of 2′‐Deoxyisoguanosine 5′‐Triphosphate and 2′‐Deoxy‐5‐methylisocytidine 5′‐Triphosphate

S. Benner, J. T. Kodra, Jeong Ho Park, 1999 .

Synthesis of Oligonucleotides Containing 2′‐Deoxyisoguanosine and 2′‐Deoxy‐5‐methylisocytidine Using Phosphoramidite Chemistry

S. Benner, J. Rozzell, J. T. Kodra, 1998 .

Using evolutionary information and ancestral sequences to understand the sequence-function relationship in GLP-1 agonists.

David A Liberles, Dennis Madsen, Marie Skovgaard, 2006, Journal of molecular biology.

Linking sequence to function in drug design with ancestral sequence reconstruction

D. Liberles, M. Skovgaard, D. Madsen, 2007 .

Redesigning nucleic acids

S. Benner, J. Piccirilli, K. Nambiar, 1998, Pure and applied chemistry. Chimie pure et appliquee.

Engineering of Orally Available, Ultralong-Acting Insulin Analogues: Discovery of OI338 and OI320.

H. H. Refsgaard, M. Münzel, L. Hovgaard, 2020, Journal of medicinal chemistry.

GLP ‐1 Receptor Agonists for the Treatment of Type 2 Diabetes and Obesity

T. Kruse, Lars Linderoth, J. T. Kodra, 2021 .